Loading...
Products:Cell Biology >> Apoptosis >> Nucleus >> PARP
MSCatalog No. MS777
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-Cleaved PARP antibody [4B5BD2]
See all Cleaved PARP products (10) ...
Mouse monoclonal [4B5BD2] to Cleaved PARP
ab110315 reacts with the N-terminal end formed by the cleavage adjacent to Asp214; it thus recognizes the apoptosis-specific 89 kDa catalytic domain fragment, but it does not recognize the full-length PARP-1 or the 24 kDa DNA binding domain fragment.
WB, ICC/IF, In-Cell ELISA, Flow Cytmore details
Reacts with
Human
Staurosporine-treated HeLa and HL60 cells
Liquid
Store at +4°C. Do not freeze.
Preservative: 0.02% Sodium azide
Constituent: HBS
Concentration information loading...
Ammonium Sulphate Precipitation
The antibody was produced in vitro using hybridomas grown in serum-free medium, and then purified by ammonium sulfate precipiation.
Monoclonal
4B5BD2
IgG1
kappa
Metabolism >> Pathways and Processes >> Metabolism processes >> Apoptosis
Epigenetics and Nuclear Signaling >> Cell cycle >> Apoptosis >> Nuclear
Epigenetics and Nuclear Signaling >> DNA / RNA >> DNA Damage & Repair >> DNA Damage Response >> DNA Damage Recognition
Epigenetics and Nuclear Signaling >> Chromatin Modifying Enzymes >> ADP-ribosylation
Cell Biology >> Apoptosis >> Nucleus >> PARP
Our Abpromise guarantee covers the use of ab110315 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: Use a concentration of 0.25 - 1 µg/ml. Predicted molecular weight: 113 kDa.
ICC/IF: Use a concentration of 1 µg/ml.
In-Cell ELISA: Use a concentration of 1 µg/ml.
Flow Cyt: Use a concentration of 1 µg/ml.
Involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. This modification follows DNA damages and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks. Mediates the poly(ADP-ribosyl)ation of APLF and CHFR. Positively regulates the transcription of MTUS1 and negatively regulates the transcription of MTUS2/TIP150.
Contains 1 BRCT domain.
Contains 1 PARP alpha-helical domain.
Contains 1 PARP catalytic domain.
Contains 2 PARP-type zinc fingers.
Phosphorylated by PRKDC. Phosphorylated upon DNA damage, probably by ATM or ATR.
Poly-ADP-ribosylated by PARP2. Poly-ADP-ribosylation mediates the recruitment of CHD1L to DNA damage sites.
S-nitrosylated, leading to inhibit transcription regulation activity.
Nucleus.
Target information above from: UniProt accessionP09874
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Immunocytochemistry/ Immunofluorescence - Cleaved PARP antibody [4B5BD2] (ab110315)
![Immunocytochemistry/ Immunofluorescence - Cleaved PARP antibody [4B5BD2] (ab110315)](/ps/datasheet/images/110/ab110315/Cleaved-PARP-Primary-antibodies-ab110315-5.jpg)
Immunocytochemistry images of stained untreated (A) and 4 hours 1 µM Staurosporine-treated (B) Human HeLa cells. The cells were paraformaldehyde fixed (4%, 20 minutes) and Triton X-100 permeabilized (0.1%, 15 minutes). The cells were incubated with 1.0 µg/ml ab110315 for 2 hours at room temperature or over night at 4°C. 10% goat serum was used as the blocking agent for all blocking steps. The secondary antibody was Alexa Fluor® 488 goat anti-mouse IgG (H+L) (in green) used at 2.0 µg/ml for 2 hours. DAPI was used to stain the cell nuclei (in red). Heat induced antigen retrieval (0.1 M Tris-HCl, 5% urea, pH 9.5 for 5 min at 95°C) improves signal. Note that the ab110315 labels only condensed and/or fragmented nuclei of apoptotic Staurosporine-treated cells.
Western blot - Anti-Cleaved PARP antibody [4B5BD2] (ab110315)
![Western blot - Anti-Cleaved PARP antibody [4B5BD2] (ab110315)](/ps/datasheet/images/110/ab110315/Cleaved-PARP-Primary-antibodies-ab110315-8.gif)
Lanes 1 - 2 : Antibody that recognizes full-length PARP1
Lanes 3 - 4 : Anti-Cleaved PARP antibody [4B5BD2] (ab110315) at 1 µg/ml
Lane 1 : untreated HeLa cells
Lane 2 : HeLa cells treated with 1 µM Staurosporinefor 4 hours
Lane 3 : untreated HeLa cells
Lane 4 : HeLa cells treated with 1 µM Staurosporinefor 4 hours
Lysates/proteins at 20 µg per lane.
Predicted band size : 113 kDa
Western Blot analysis using ab110315 antibody and 20 µg of untreated (CON) or 4 hours 1 µM Staurosporine-treated (STS) HeLa cells. Blots were incubated with an antibody that recognizes both the full-length PARP-1 and its 89 kDa fragment (left panel), or 1.0 µg/mL PARP-1 (cleaved) antibody (ab110315) (right panel). Appropriate HRP-conjugated secondary antibodies followed by ECL detection were used. Note that the MS777 antibody recognizes the apoptosis-specific 89 kDa fragment of PARP-1 but it does not recognize the full-length PARP-1.
In-Cell ELISA - Cleaved PARP antibody [4B5BD2] (ab110315)
![In-Cell ELISA - Cleaved PARP antibody [4B5BD2] (ab110315)](/ps/datasheet/images/110/ab110315/Cleaved-PARP-Primary-antibodies-ab110315-3.gif)
In-Cell ELISA (ICE) using ab110315 on HeLa cells treated with Staurosporine to induce apoptosis. HeLa cells were seeded overnight (50,000 cells/well), treated for 4 hours with 1 µM Staurosporine or with the drug vehicle (DMSO), fixed for Detaching Adherent Cells and analyze.
Flow Cytometry - Cleaved PARP antibody [4B5BD2] (ab110315)
![Flow Cytometry - Cleaved PARP antibody [4B5BD2] (ab110315)](/ps/datasheet/images/110/ab110315/Cleaved-PARP-Primary-antibodies-ab110315-7.jpg)
Flow cytometry analysis of apoptosis using ab110315. HL-60 cells were treated with 1 µM Staurosporin for 4 hours (blue) or vehicle control (red). Control cells were also stained with an equal amount of an isotype control antibody (black).
ab110315 has not yet been referenced specifically in any publications.
Publishing research using ab110315? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Immunocytochemistry/ Immunofluorescence - Cleaved PARP antibody [4B5BD2] (ab110315)](/ps/datasheet/images/110/ab110315/Cleaved-PARP-Primary-antibodies-ab110315-5.jpg)
Immunocytochemistry images of stained untreated (A) and 4 hours 1 µM Staurosporine-treated (B) Human HeLa cells. The cells were paraformaldehyde fixed (4%, 20 minutes) and Triton X-100 permeabilized (0.1%, 15 minutes). The cells were incubated with 1.0 µg/ml ab110315 for 2 hours at room temperature or over night at 4°C. 10% goat serum was used as the blocking agent for all blocking steps. The secondary antibody was Alexa Fluor® 488 goat anti-mouse IgG (H+L) (in green) used at 2.0 µg/ml for 2 hours. DAPI was used to stain the cell nuclei (in red). Heat induced antigen retrieval (0.1 M Tris-HCl, 5% urea, pH 9.5 for 5 min at 95°C) improves signal. Note that the ab110315 labels only condensed and/or fragmented nuclei of apoptotic Staurosporine-treated cells.
![Western blot - Anti-Cleaved PARP antibody [4B5BD2] (ab110315)](/ps/datasheet/images/110/ab110315/Cleaved-PARP-Primary-antibodies-ab110315-8.gif)
Western Blot analysis using ab110315 antibody and 20 µg of untreated (CON) or 4 hours 1 µM Staurosporine-treated (STS) HeLa cells. Blots were incubated with an antibody that recognizes both the full-length PARP-1 and its 89 kDa fragment (left panel), or 1.0 µg/mL PARP-1 (cleaved) antibody (ab110315) (right panel). Appropriate HRP-conjugated secondary antibodies followed by ECL detection were used. Note that the MS777 antibody recognizes the apoptosis-specific 89 kDa fragment of PARP-1 but it does not recognize the full-length PARP-1.
![In-Cell ELISA - Cleaved PARP antibody [4B5BD2] (ab110315)](/ps/datasheet/images/110/ab110315/Cleaved-PARP-Primary-antibodies-ab110315-3.gif)
In-Cell ELISA (ICE) using ab110315 on HeLa cells treated with Staurosporine to induce apoptosis. HeLa cells were seeded overnight (50,000 cells/well), treated for 4 hours with 1 µM Staurosporine or with the drug vehicle (DMSO), fixed for Detaching Adherent Cells and analyze.
![Flow Cytometry - Cleaved PARP antibody [4B5BD2] (ab110315)](/ps/datasheet/images/110/ab110315/Cleaved-PARP-Primary-antibodies-ab110315-7.jpg)
Flow cytometry analysis of apoptosis using ab110315. HL-60 cells were treated with 1 µM Staurosporin for 4 hours (blue) or vehicle control (red). Control cells were also stained with an equal amount of an isotype control antibody (black).
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
